{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:06:46Z","timestamp":1794377206470,"version":"4.9.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41401-025-01491-0","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T10:52:13Z","timestamp":1739789533000},"page":"1556-1566","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Kr\u00fcppel-like factor 9 alleviates Alzheimer\u2019s disease via IDE-mediated A\u03b2 degradation"],"prefix":"10.1038","volume":"46","author":[{"given":"Yue-yao","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-ran","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-tong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-jin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-fan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-yuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-sheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"1491_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener. 2019;14:32.","journal-title":"Mol Neurodegener"},{"key":"1491_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1212\/WNL.0000000000001831","volume":"85","author":"CH Kawas","year":"2015","unstructured":"Kawas CH, Kim RC, Sonnen JA, Bullain SS, Trieu T, Corrada MM. Multiple pathologies are common and related to dementia in the oldest-old: The 90+ Study. Neurology. 2015;85:535\u201342.","journal-title":"Neurology"},{"key":"1491_CR3","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.2147\/IJN.S200490","volume":"14","author":"S Tiwari","year":"2019","unstructured":"Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M. Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine. 2019;14:5541\u201354.","journal-title":"Int J Nanomedicine"},{"key":"1491_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC, Chetelat G, Holtzman DM, Hyman BT, et al. Alzheimer disease. Nat Rev Dis Primers. 2021;7:33.","journal-title":"Nat Rev Dis Primers"},{"key":"1491_CR5","doi-asserted-by":"crossref","unstructured":"2023 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 2023;19:1598\u2013695.","DOI":"10.1002\/alz.13016"},{"key":"1491_CR6","doi-asserted-by":"publisher","first-page":"a006379","DOI":"10.1101\/cshperspect.a006379","volume":"2","author":"T Saido","year":"2012","unstructured":"Saido T, Leissring MA. Proteolytic degradation of amyloid beta-protein. Cold Spring Harb Perspect Med. 2012;2:a006379.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1491_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-024-00434-9","volume":"13","author":"N Liu","year":"2024","unstructured":"Liu N, Haziyihan A, Zhao W, Chen Y, Chao H. Trajectory of brain-derived amyloid beta in Alzheimer\u2019s disease: where is it coming from and where is it going? Transl Neurodegener. 2024;13:42.","journal-title":"Transl Neurodegener"},{"key":"1491_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med. 2016;8:595\u2013608.","journal-title":"EMBO Mol Med"},{"key":"1491_CR9","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, et al. Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science. 2010;330:1774.","journal-title":"Science"},{"key":"1491_CR10","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1111\/bph.14593","volume":"176","author":"NN Nalivaeva","year":"2019","unstructured":"Nalivaeva NN, Turner AJ. Targeting amyloid clearance in Alzheimer\u2019s disease as a therapeutic strategy. Br J Pharmacol. 2019;176:3447\u201363.","journal-title":"Br J Pharmacol"},{"key":"1491_CR11","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","volume":"40","author":"MA Leissring","year":"2003","unstructured":"Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun X, et al. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron. 2003;40:1087\u201393.","journal-title":"Neuron"},{"key":"1491_CR12","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/pharmaceutics16070948","volume":"16","author":"S Petralla","year":"2024","unstructured":"Petralla S, Panayotova M, Franchina E, Fricker G, Puris E. Low-density lipoprotein receptor-related protein 1 as a potential therapeutic target in Alzheimer\u2019s disease. Pharmaceutics. 2024;16:948.","journal-title":"Pharmaceutics"},{"key":"1491_CR13","doi-asserted-by":"crossref","unstructured":"Kang C. Donanemab: first approval. Drugs. 2024;84:1313\u20138.","DOI":"10.1007\/s40265-024-02087-4"},{"key":"1491_CR14","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s40265-021-01569-z","volume":"81","author":"S Dhillon","year":"2021","unstructured":"Dhillon S. Aducanumab: first approval. Drugs. 2021;81:1437\u201343.","journal-title":"Drugs"},{"key":"1491_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s40265-023-01851-2","volume":"83","author":"SM Hoy","year":"2023","unstructured":"Hoy SM. Lecanemab: first approval. Drugs. 2023;83:359\u201365.","journal-title":"Drugs"},{"key":"1491_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0014-5793(94)00387-4","volume":"345","author":"IV Kurochkin","year":"1994","unstructured":"Kurochkin IV, Goto S. Alzheimer\u2019s beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 1994;345:33\u20137.","journal-title":"FEBS Lett"},{"key":"1491_CR17","doi-asserted-by":"publisher","first-page":"8745","DOI":"10.1523\/JNEUROSCI.20-23-08745.2000","volume":"20","author":"A Mukherjee","year":"2000","unstructured":"Mukherjee A, Song E, Kihiko-Ehmann M, Goodman JP Jr, Pyrek JS, Estus S, et al. Insulysin hydrolyzes amyloid beta peptides to products that are neither neurotoxic nor deposit on amyloid plaques. J Neurosci. 2000;20:8745\u20139.","journal-title":"J Neurosci"},{"key":"1491_CR18","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","volume":"20","author":"K Vekrellis","year":"2000","unstructured":"Vekrellis K, Ye Z, Qiu WQ, Walsh D, Hartley D, Chesneau V, et al. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci. 2000;20:1657\u201365.","journal-title":"J Neurosci"},{"key":"1491_CR19","doi-asserted-by":"publisher","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","volume":"273","author":"WQ Qiu","year":"1998","unstructured":"Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB, et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem. 1998;273:32730\u20138.","journal-title":"J Biol Chem"},{"key":"1491_CR20","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1021\/bi011193l","volume":"41","author":"S Sudoh","year":"2002","unstructured":"Sudoh S, Frosch MP, Wolf BA. Differential effects of proteases involved in intracellular degradation of amyloid beta-protein between detergent-soluble and -insoluble pools in CHO-695 cells. Biochemistry. 2002;41:1091\u20139.","journal-title":"Biochemistry"},{"key":"1491_CR21","doi-asserted-by":"publisher","first-page":"36621","DOI":"10.1074\/jbc.M006170200","volume":"275","author":"RG Bennett","year":"2000","unstructured":"Bennett RG, Duckworth WC, Hamel FG. Degradation of amylin by insulin-degrading enzyme. J Biol Chem. 2000;275:36621\u20135.","journal-title":"J Biol Chem"},{"key":"1491_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0002-9440(10)63822-9","volume":"162","author":"DG Cook","year":"2003","unstructured":"Cook DG, Leverenz JB, McMillan PJ, Kulstad JJ, Ericksen S, Roth RA, et al. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer\u2019s disease is associated with the apolipoprotein E-epsilon4 allele. Am J Pathol. 2003;162:313\u20139.","journal-title":"Am J Pathol"},{"key":"1491_CR23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2174\/1874609809666161111101111","volume":"10","author":"NN Nalivaeva","year":"2017","unstructured":"Nalivaeva NN, Turner AJ. Role of ageing and oxidative stress in regulation of amyloid-degrading enzymes and development of neurodegeneration. Curr Aging Sci. 2017;10:32\u201340.","journal-title":"Curr Aging Sci"},{"key":"1491_CR24","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/S0002-9440(10)63229-4","volume":"164","author":"W Farris","year":"2004","unstructured":"Farris W, Mansourian S, Leissring MA, Eckman EA, Bertram L, Eckman CB, et al. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am J Pathol. 2004;164:1425\u201334.","journal-title":"Am J Pathol"},{"key":"1491_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101283","volume":"26","author":"C de Dios","year":"2019","unstructured":"de Dios C, Bartolessis I, Roca-Agujetas V, Barbero-Camps E, Mari M, Morales A, et al. Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress. Redox Biol. 2019;26:101283.","journal-title":"Redox Biol"},{"key":"1491_CR26","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1073\/pnas.0230450100","volume":"100","author":"W Farris","year":"2003","unstructured":"Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA. 2003;100:4162\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1491_CR27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/path.5777","volume":"255","author":"L Sousa","year":"2021","unstructured":"Sousa L, Guarda M, Meneses MJ, Macedo MP, Vicente Miranda H. Insulin-degrading enzyme: an ally against metabolic and neurodegenerative diseases. J Pathol. 2021;255:346\u201361.","journal-title":"J Pathol"},{"key":"1491_CR28","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1042\/BST0331101","volume":"33","author":"EA Eckman","year":"2005","unstructured":"Eckman EA, Eckman CB. Abeta-degrading enzymes: modulators of Alzheimer\u2019s disease pathogenesis and targets for therapeutic intervention. Biochem Soc Trans. 2005;33:1101\u20135.","journal-title":"Biochem Soc Trans"},{"key":"1491_CR29","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1002\/j.1460-2075.1992.tb05451.x","volume":"11","author":"H Imataka","year":"1992","unstructured":"Imataka H, Sogawa K, Yasumoto K, Kikuchi Y, Sasano K, Kobayashi A, et al. Two regulatory proteins that bind to the basic transcription element (BTE), a GC box sequence in the promoter region of the rat P-4501A1 gene. EMBO J. 1992;11:3663\u201371.","journal-title":"EMBO J"},{"key":"1491_CR30","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.2337\/db19-1153","volume":"69","author":"H Fan","year":"2020","unstructured":"Fan H, Zhang Y, Zhang J, Yao Q, Song Y, Shen Q, et al. Cold-inducible Klf9 regulates thermogenesis of brown and Beige fat. Diabetes. 2020;69:2603\u201318.","journal-title":"Diabetes"},{"key":"1491_CR31","doi-asserted-by":"publisher","first-page":"9875","DOI":"10.1523\/JNEUROSCI.2260-09.2009","volume":"29","author":"KN Scobie","year":"2009","unstructured":"Scobie KN, Hall BJ, Wilke SA, Klemenhagen KC, Fujii-Kuriyama Y, Ghosh A, et al. Kruppel-like factor 9 is necessary for late-phase neuronal maturation in the developing dentate gyrus and during adult hippocampal neurogenesis. J Neurosci. 2009;29:9875\u201387.","journal-title":"J Neurosci"},{"key":"1491_CR32","doi-asserted-by":"publisher","first-page":"e72195","DOI":"10.7554\/eLife.72195","volume":"11","author":"N Guo","year":"2022","unstructured":"Guo N, McDermott KD, Shih YT, Zanga H, Ghosh D, Herber C, et al. Transcriptional regulation of neural stem cell expansion in the adult hippocampus. Elife. 2022;11:e72195.","journal-title":"Elife"},{"key":"1491_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.expneurol.2017.10.025","volume":"300","author":"EF Trakhtenberg","year":"2018","unstructured":"Trakhtenberg EF, Li Y, Feng Q, Tso J, Rosenberg PA, Goldberg JL, et al. Zinc chelation and Klf9 knockdown cooperatively promote axon regeneration after optic nerve injury. Exp Neurol. 2018;300:22\u20139.","journal-title":"Exp Neurol"},{"key":"1491_CR34","doi-asserted-by":"publisher","first-page":"e0222921","DOI":"10.1371\/journal.pone.0222921","volume":"14","author":"JA Potashkin","year":"2019","unstructured":"Potashkin JA, Bottero V, Santiago JA, Quinn JP. Computational identification of key genes that may regulate gene expression reprogramming in Alzheimer\u2019s patients. PLoS One. 2019;14:e0222921.","journal-title":"PLoS One"},{"key":"1491_CR35","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1007\/s00125-016-4043-z","volume":"59","author":"Y Cui","year":"2016","unstructured":"Cui Y, Qiao A, Jiao T, Zhang H, Xue Y, Zou Y, et al. The hepatic FOXQ1 transcription factor regulates glucose metabolism in mice. Diabetologia. 2016;59:2229\u201339.","journal-title":"Diabetologia"},{"key":"1491_CR36","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1172\/JCI66062","volume":"129","author":"A Cui","year":"2019","unstructured":"Cui A, Fan H, Zhang Y, Zhang Y, Niu D, Liu S, et al. Dexamethasone-induced Kruppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia. J Clin Invest. 2019;129:2266\u201378.","journal-title":"J Clin Invest"},{"key":"1491_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tips.2017.10.008","volume":"39","author":"IV Kurochkin","year":"2018","unstructured":"Kurochkin IV, Guarnera E, Berezovsky IN. Insulin-degrading enzyme in the fight against Alzheimer\u2019s disease. Trends Pharmacol Sci. 2018;39:49\u201358.","journal-title":"Trends Pharmacol Sci"},{"key":"1491_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101999","volume":"90","author":"Y Tian","year":"2023","unstructured":"Tian Y, Jing G, Zhang M. Insulin-degrading enzyme: Roles and pathways in ameliorating cognitive impairment associated with Alzheimer\u2019s disease and diabetes. Ageing Res Rev. 2023;90:101999.","journal-title":"Ageing Res Rev"},{"key":"1491_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/biomedicines9010086","volume":"9","author":"CM Gonzalez-Casimiro","year":"2021","unstructured":"Gonzalez-Casimiro CM, Merino B, Casanueva-Alvarez E, Postigo-Casado T, Camara-Torres P, Fernandez-Diaz CM, et al. Modulation of insulin sensitivity by insulin-degrading enzyme. Biomedicines. 2021;9:86.","journal-title":"Biomedicines"},{"key":"1491_CR40","first-page":"3277","volume":"22","author":"Q Quan","year":"2020","unstructured":"Quan Q, Li X, Feng J, Hou J, Li M, Zhang B. Ginsenoside Rg1 reduces \u03b2\u2011amyloid levels by inhibiting CD\u039a5\u2011induced PPAR\u03b3 phosphorylation in a neuron model of Alzheimer\u2019s disease. Mol Med Rep. 2020;22:3277\u201388.","journal-title":"Mol Med Rep"},{"key":"1491_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117564","volume":"321","author":"Y Li","year":"2024","unstructured":"Li Y, Wu H, Liu M, Zhang Z, Ji Y, Xu L, et al. Polysaccharide from Polygala tenuifolia alleviates cognitive decline in Alzheimer\u2019s disease mice by alleviating Abeta damage and targeting the ERK pathway. J Ethnopharmacol. 2024;321:117564.","journal-title":"J Ethnopharmacol"},{"key":"1491_CR42","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.neuint.2018.09.005","volume":"120","author":"KW Chang","year":"2018","unstructured":"Chang KW, Zong HF, Ma KG, Zhai WY, Yang WN, Hu XD, et al. Activation of alpha7 nicotinic acetylcholine receptor alleviates Abeta(1-42)-induced neurotoxicity via downregulation of p38 and JNK MAPK signaling pathways. Neurochem Int. 2018;120:238\u201350.","journal-title":"Neurochem Int"},{"key":"1491_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12986-019-0377-0","volume":"16","author":"Y Kim","year":"2019","unstructured":"Kim Y, Rouse M, Gonzalez-Mariscal I, Egan JM, O\u2019Connell JF. Dietary curcumin enhances insulin clearance in diet-induced obese mice via regulation of hepatic PI3K-AKT axis and IDE, and preservation of islet integrity. Nutr Metab. 2019;16:48.","journal-title":"Nutr Metab"},{"key":"1491_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bbi.2012.12.003","volume":"30","author":"V Lifshitz","year":"2013","unstructured":"Lifshitz V, Benromano T, Weiss R, Blanga-Kanfi S, Frenkel D. Insulin-degrading enzyme deficiency accelerates cerebrovascular amyloidosis in an animal model. Brain Behav Immun. 2013;30:143\u20139.","journal-title":"Brain Behav Immun"},{"key":"1491_CR45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/BF03346691","volume":"34","author":"Y Liu","year":"2011","unstructured":"Liu Y, Liu L, Lu S, Wang D, Liu X, Xie L, et al. Impaired amyloid beta-degrading enzymes in brain of streptozotocin-induced diabetic rats. J Endocrinol Invest. 2011;34:26\u201331.","journal-title":"J Endocrinol Invest"},{"key":"1491_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbi.2024.02.016","volume":"118","author":"K Zhao","year":"2024","unstructured":"Zhao K, Liu J, Sun T, Zeng L, Cai Z, Li Z, et al. The miR-25802\/KLF4\/NF-kappaB signaling axis regulates microglia-mediated neuroinflammation in Alzheimer\u2019s disease. Brain Behav Immun. 2024;118:31\u201348.","journal-title":"Brain Behav Immun"},{"key":"1491_CR47","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13195-022-01050-3","volume":"14","author":"Y Wang","year":"2022","unstructured":"Wang Y, Cui Y, Liu J, Song Q, Cao M, Hou Y, et al. Kruppel-like factor 5 accelerates the pathogenesis of Alzheimer\u2019s disease via BACE1-mediated APP processing. Alzheimers Res Ther. 2022;14:103.","journal-title":"Alzheimers Res Ther"},{"key":"1491_CR48","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1016\/j.celrep.2018.05.040","volume":"23","author":"A Besnard","year":"2018","unstructured":"Besnard A, Langberg T, Levinson S, Chu D, Vicidomini C, Scobie KN, et al. Targeting Kruppel-like Factor 9 in excitatory neurons protects against chronic stress-induced impairments in dendritic spines and fear responses. Cell Rep. 2018;23:3183\u201396.","journal-title":"Cell Rep"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01491-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01491-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01491-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T11:04:06Z","timestamp":1747911846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01491-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1491"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01491-0","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}